Treatment of acne vulgaris in pregnant patients

  title={Treatment of acne vulgaris in pregnant patients},
  author={Rupa Pugashetti and Kanade Shinkai},
  journal={Dermatologic Therapy},
The management of acne vulgaris in the setting of pregnancy raises important clinical considerations regarding the efficacy and safety of acne treatments in this special patient population. Particular challenges include the absence of safety data, discrepancy in safety data between different safety rating systems, and lack of evidence‐based recommendations for the treatment of acne during pregnancy. Nonetheless, many therapeutic options exist, and the treatment of acne in pregnant women can be… 

Treatment of Acne in Pregnancy

The safety profile of common therapies and outline approaches based on available evidence are described, including complementary therapies including micronutrients and nonpharmacologic treatments seem to be well tolerated.

Treatment of Acne Vulgaris During Pregnancy and Lactation: A Narrative Review

Current evidence on the safety and efficacy of acne treatments during pregnancy and breastfeeding is summarized to aid patient-physician decision-making on acne management in special populations.

Management of severe acne during pregnancy: A case report and review of the literature☆☆☆

  • S. AwanJ. Lu
  • Medicine
    International journal of women's dermatology
  • 2017

Acneiform Eruptions and Pregnancy

A acneiform eruptions during pregnancy, including acne vulgaris, acne rosacea, perioral dermatitis, and hidradenitis suppurativa are reviewed focusing on maternal and fetal safety.

Management of Acne Vulgaris: A Review.

Isotretinoin is approved by the US Food and Drug Administration for treating severe recalcitrant nodular acne but is often used to treat resistant or persistent moderate to severe acne, as well as acne that produces scarring or significant psychosocial distress.

Acneiform Eruptions and Pregnancy Acneiform Eruptions and Pregnancy

A acneiform eruptions during pregnancy, including acne vulgaris, acne rosacea, perioral dermatitis, and hidradenitis suppurativa are reviewed focusing on maternal and fetal safety.

Acne Management Guidelines by the Dermatological Society of Singapore.

These treatment guidelines outline recommendations for the diagnosis, grading, and treatment of children, adolescents, and adults with acne of varying severity, and include advice pertaining to the use of cosmeceuticals and management of scars.

The Effectiveness of Autologous Serum and Single-dose Oral Doxycycline in the Treatment of Acne Vulgaris: A Pilot Clinical Trial

Assessment of the effectiveness of autologous serum and single-dose oral doxycycline in the treatment of acne vulgaris showed superior improvement of inflammatory acne lesions, with significant decrease in lesion count.

Acne and Rosacea in Pregnancy

The clinical management of acne and rosacea during pregnancy and lactation requires special attention to detail and few of these treatments have been adequately studied for efficacy and safety in the pregnant population.

The susceptibility of pathogens associated with acne vulgaris to antibiotics

Doxycycline and minocycline showed 100% effectiveness for P. acnes and S. aureus, and the use of clindamycin and erythromycin needs to be limited as most S. epidermidis isolates were resistant to both.



Azithromycin versus tetracycline in the treatment of acne vulgaris

Azithromycin is a safe and effective alternative in the treatment of inflammatory acne and a slightly higher percentage of improvement compared with tetracycline.

Acne in ethnic skin: special considerations for therapy

Clinicians must find a balance between aggressive early intervention to target inflammatory acne lesions, and gentle treatments to increase tolerability and avoid skin irritation in patients of color.

New antibiotic therapies for acne and rosacea

The latest studies suggest anti‐inflammatory actions to be the most likely mechanism of antibiotics in acne and rosacea, shifting the focus to subantimicrobial‐dose oral antibiotics and/or topical antibiotic regimens as the preferred first‐line agents.

Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris

It is indicated that azithromycin is at least as effective as doxycycline in the treatment of acne and Statistically significant improvement for the facial lesions were obtained with both drugs.

Acne vulgaris in the United States: a descriptive epidemiology.

This analysis only included patients who sought treatment of their acne and may underestimate the total prevalence of acne in the population, but it is clear that acne is a disease that affects all age groups, not just adolescents.

Effect of photodynamic therapy on inflammatory acne using 3% liposomal 5‐aminolevulinic acid emulsion and intense‐pulsed light: A pilot study

Although there is no direct evidence to diagnose this case as a drug eruption caused by sitagliptin, even in Japanese postmarketing reports of sitaglisptin, there were 23 cases of drug eruption, including two cases of Stevens–Johnson syndrome, so it seems that although there has been only one case report published, drug eruption is not rare, leading to a lack of recognition of sitgliptin-induced allergic reaction.

Safety of skin care products during pregnancy.

With the exception of hydroquinone, which has a relatively high systemic absorption rate, and tretinoin, for which the evidence is controversial, these products act locally and therefore produce minimal systemic levels, and in most cases women can deal with these cosmetically unappealing skin conditions without compromising the safety of their unborn children.

Update on topical antibiotics in dermatology

The following discussion will review an update on topical antibiotic use in acne, wound care, impetigo, and in staphylococcal nasal carriers.

Narrowband UV-B phototherapy for the treatment of acne vulgaris during pregnancy.

  • J. Zeichner
  • Medicine, Biology
    Archives of dermatology
  • 2011
Narrowband (NB) UV-B phototherapy is a safe option for treatment of psoriasis during pregnancy and the successful use of NBUV-B for the treatment of acne in a pregnant patient is reported.